ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
twitter youtube facebook linkedin iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Meeting News

New Texas Lung Cancer Conference Planned with Busy Clinicians in Mind

Erin Jungmeyer
on: March 21, 2023In: Meeting News
New Texas Lung Cancer Conference Planned with Busy Clinicians in Mind

Stephen Liu, MD, and Tina Cascone, MD, PhD, share what attendees can expect at the first ever Texas Lung Cancer Conference, an upcoming two-day CME meeting endorsed by the IASLC. Read more


ILCN Editor Dr. Corey J. Langer Reflects on the ‘Fantastic Voyage’ From Nihilism to Hope in Thoracic Oncology

Nick Ippolito
on: March 21, 2023In: Meeting News
ILCN Editor Dr. Corey J. Langer Reflects on the ‘Fantastic Voyage’ From Nihilism to Hope in Thoracic Oncology

In addressing fellow TTLC 23 faculty, Dr. Langer recounted the perils and pitfalls, promises and poetry he has experienced in his 35 years in the field. Read more

Specialists Debate the Merits of Lorlatinib as a Universal First-Line Treatment for ALK+ Patients

Nick Ippolito
on: March 21, 2023In: Meeting News
Specialists Debate the Merits of Lorlatinib as a Universal First-Line Treatment for ALK+ Patients

Dr. Lyudmila Bazhenova argues the drug’s superior PFS makes it the best first choice; however Dr. Justin Gainor says toxicity data show it may not be right for all patients. Read more

Study Explores First-Line Osimertinib for NSCLC Patients with Uncommon EGFR Mutations

Erin Jungmeyer
on: March 21, 2023In: Meeting News
Study Explores First-Line Osimertinib for NSCLC Patients with Uncommon EGFR Mutations

During TTLC 23, Johns Hopkins’ Tia Cheunkarndee presented data that highlight the vast heterogeneity of mutations—and their variable response to treatment. Read more

TTLC Keynote Speaker Explores Progress, Potential Breakthroughs of SCLC Therapies

Nick Ippolito
on: March 07, 2023In: Meeting News
TTLC Keynote Speaker Explores Progress, Potential Breakthroughs of SCLC Therapies

During the Targeted Therapies of Lung Cancer meeting, MD Anderson’s Dr. Lauren Byers celebrated recent advances and highlighted areas in need of further research. Read more

Experts Debate TKI Use After Disease Progression for Patients with EGFR Mutations

Nick Ippolito
on: March 07, 2023In: Meeting News
Experts Debate TKI Use After Disease Progression for Patients with EGFR Mutations

During TTLC 23, Drs. Balazs Halmos and Mark Socinski presented the evidence for and against continued tyrosine kinase inhibitors use with chemotherapy for EGFR-positive patients with disease progression. Read more

Scenes from TTLC 2023

Steve Parker
on: March 07, 2023In: Meeting News
Scenes from TTLC 2023

Revisit all your favorite moments from #TTLC23 in our photo gallery. Read more

TTLC 2023 Showcases Early Ongoing Trial Data, Newest Therapies

Erin Jungmeyer
on: February 21, 2023In: Meeting News
TTLC 2023 Showcases Early Ongoing Trial Data, Newest Therapies

Conference chairs Drs. Paul Bunn, Charu Aggarwal, Lecia Sequist, and Joel Neal discuss what makes this meeting unique and share program highlights in a recent Q&A with ILCN. Read more

In Brief for Feb. 22, 2023

Erin Jungmeyer
on: February 21, 2023In: Meeting News, Society News
In Brief for Feb. 22, 2023

IASLC is now accepting abstract submissions for WCLC 2023 and nominations for committee membership and leadership. Read more

Increasing Evidence Demonstrates the Usefulness of ctDNA

Christian Rolfo, MD, PhD, MBA, Drhc
+more
on: February 07, 2023In: Evolving Standards of Care, Meeting News
Increasing Evidence Demonstrates the Usefulness of ctDNA

LALCA participants recap how the field of liquid biopsy continues to grow—from new biomarkers to new frontiers in early cancer detection. Read more

1234›»
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2023 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy